title: [Charter of medicines promotion and rational use by physicians].
abstract: The charter of medicines promotion recently adopted by France intends to constrain information given by sales representatives to the field of good prescription practices. Over a 11 year period (1994 to end 2004), 362 interdictions of promotional supports have been decided by the director of the French Medicines Agency. This accounts for 0.5% of the about 80 800 promotional supports controlled during this period. A date base shows the representation of the justifications of these interdictions and the predominance of documentation given or showed to the physicians. A challenge for health authorities would be to assess the actual impact of ethical and non ethical promotion.
authors: INSERM U657, IFR 99, Université Victor Segalen Bordeaux 2, France. Marie.Baumevieille@deph.u-bordeaux2.fr
authors: Marie
authors: M
authors: Baumevieille
authors: Bernard
authors: B
authors: Bégaud
authors: Catherine
authors: C
authors: Maurain
mesh_terms: D004345:Drug Industry / Q000941:ethics / Q000331:legislation & jurisprudence*; D011307:Drug Prescriptions / Q000592:standards; D005602:France; D007880:Legislation, Drug / Q000639:trends*; D040541:Marketing / Q000941:ethics / Q000592:standards